---
document_datetime: 2023-09-21 18:08:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/lantus-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: lantus-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.3859244
conversion_datetime: 2025-12-19 21:14:16.777703
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 September 2003 please refer to module 8B.

| Scope                                                                                                                                                                                                                                                                                                           | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Change to the manufacturing process of the active substance                                                                                                                                                                                                                                                     | II/0001              | II                       | 19/10/2000                          | -                                       |
| Additional presentations: Lantus OptiSet, solution for injection in 3 ml pre-filled pens: packs of 3, 4, 5 and 10 pens                                                                                                                                                                                          | II/0002              | II                       | 19/10/2000                          | 06/02/2001                              |
| Change to the manufacturing process of the active substance                                                                                                                                                                                                                                                     | II/0003              | II                       | 01/03/2001                          | -                                       |
| Demonstration of TSE compliance                                                                                                                                                                                                                                                                                 | II/0004              | II                       | 26/04/2001                          | -                                       |
| Change in the insulin glargine production process                                                                                                                                                                                                                                                               | II/0005              | II                       | 27/06/2001                          | -                                       |
| Addition of a new volume vial of 10 ml                                                                                                                                                                                                                                                                          | II/0006              | II                       | 26/07/2001                          | 28/01/2002                              |
| The indication has been extended for the use of Lantus in children of 6 years or above. In addition a class wording regarding hypoglycaemic reactions after transfer from animal source insulin to human insulin has been included in section 4.4 of the SPC. The Package Leaflet has been updated accordingly. | II/0007              | II                       | 21/11/2002                          | 04/03/2003                              |
| Change in the dosing scheme for Lantus with the consequent change in section 4.2 of the SPC. In addition a warning concerning 'hypoglycaemia' has been included in section 4.4 of the SPC. The Package Leaflet has been updated accordingly.                                                                    | II/0008              | II                       | 19/09/2002                          | 05/12/2002                              |
| Additional presentations: packs of 1, 3, 6, 8, 9 cartridges and packs of 1, 6, 8, 9 pre-filled pens (OptiSet).                                                                                                                                                                                                  | I/0009               | I                        | 19/03/2003                          | 22/04/2003                              |
| Change in the batch size of finished product                                                                                                                                                                                                                                                                    | I/0010               | I/II                     | 25/04/2003                          | -                                       |
| Change in supplier of an intermediate compound used in manufacture of the active substance                                                                                                                                                                                                                      | I/0011               | I                        | 19/06/2003                          | -                                       |
| Minor change in the labelling                                                                                                                                                                                                                                                                                   | N/0013               | N                        | 29/08/2003                          | -                                       |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 61(3) of Directive 2001/83/EC of 6 November 2001.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.